Drug Type Small molecule drug |
Synonyms 17βH-Neriifolin |
Target |
Action inhibitors |
Mechanism Na/K-ATPase inhibitors(Sodium/potassium-transporting ATPase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cardiomegaly | Preclinical | Malaysia | 29 Aug 2025 | |
| Heart Failure | Preclinical | Malaysia | 29 Aug 2025 |





